|
|
|
|
|
by timr
1919 days ago
|
|
There has been a lot of (IMHO unsupported) speculation that the almost complete eradication of influenza in 2020 was due to competitive inhibition from SARS-CoV2. However, data I've seen suggests that rhinovirus is still circulating at its usual rate [1]. If it's true that rhinovirus is such a potent inhibitor of SARS-CoV2, at the very least, the interplay between SARS-CoV2 and other respiratory viruses is non-trivial, and doesn't explain the complete suppression of influenza. Any simple hypothesis involving "competitive inhibition" is likely to be wrong. The fact that rhinovirus continues to circulate so widely should also make people at least question the dominant narrative concerning masks and respiratory viruses. But I digress... [1] https://syndromictrends.com/metric/panel/rp/percent_positivi... |
|
On the research presented in the original article, what predicted implications would this research have had for March 2020? I thought 2020 seemed like a fairly average year for colds up until March, when COVID spiked. Is that suggesting this benefit/effect weaker in a population than the test measures in a individual, or just that March could have been much worse across the world? (for example, was hypothetically Italy having a very low rate of colds at the time?)